Introduction: The Default Mode Network in Health and Depression
The default mode network (DMN) -- a set of interconnected brain regions including the medial prefrontal cortex (mPFC), posterior cingulate cortex (PCC), precuneus, angular gyrus, and medial temporal lobe structures -- has emerged as a central construct in the neurobiology of depression and a key target of ketamine's neural effects. Ketamine and the default mode network have become interlinked topics in psychiatric neuroimaging research, as accumulating evidence demonstrates that sub-anesthetic ketamine produces rapid and therapeutically relevant alterations in DMN functional connectivity that correlate with clinical antidepressant response (Scheidegger et al., 2012). Understanding these network-level effects provides critical insight into ketamine's mechanism of action and holds promise for identifying neuroimaging biomarkers that can predict and monitor treatment response.
The DMN was first characterized by Raichle and colleagues (2001), published in Proceedings of the National Academy of Sciences, as a set of brain regions that demonstrate coordinated deactivation during externally directed cognitive tasks and activation during rest, self-referential thought, autobiographical memory retrieval, and future simulation. The network's role in self-referential processing has positioned it at the center of neurobiological models of depression, which conceptualize depressive rumination -- the persistent, maladaptive focus on negative self-referent thoughts -- as a consequence of DMN hyperconnectivity and dysregulated self-referential processing (Hamilton et al., 2015).
The DMN in Depression: Hyperconnectivity and Rumination
Evidence for DMN Hyperconnectivity
A robust body of resting-state functional MRI (rs-fMRI) research demonstrates altered DMN connectivity in major depressive disorder. The most consistent finding is hyperconnectivity within the DMN -- particularly between the mPFC and PCC -- in depressed individuals compared with healthy controls (Greicius et al., 2007). This hyperconnectivity is hypothesized to reflect excessive self-referential processing and the perseverative negative self-focus that characterizes depressive rumination.
Kaiser and colleagues (2015), in a large-scale meta-analysis published in JAMA Psychiatry, analyzed resting-state functional connectivity data across 25 studies encompassing over 550 depressed patients and 500 healthy controls. The analysis confirmed significant hyperconnectivity within the anterior DMN (mPFC-centered) in depression, along with reduced connectivity between the DMN and frontoparietal control network -- suggesting impaired regulatory oversight of self-referential processes.
Subgenual Anterior Cingulate Cortex
The subgenual anterior cingulate cortex (sgACC; Brodmann area 25) -- a DMN-associated region -- has been identified as a critical node in the neurocircuitry of depression. The sgACC demonstrates increased metabolic activity and functional connectivity with other DMN regions in depression, and normalization of sgACC hyperactivity is associated with antidepressant response across multiple treatment modalities, including pharmacotherapy, ECT, and deep brain stimulation (Mayberg et al., 2005). The sgACC's role as a convergent target of diverse antidepressant mechanisms positions it as a candidate neuroimaging biomarker for treatment response prediction.
Acute Effects of Ketamine on DMN Connectivity
fMRI Studies During Ketamine Infusion
Scheidegger and colleagues (2012), published in Human Brain Mapping, conducted one of the first studies examining ketamine's acute effects on resting-state networks. In 17 healthy volunteers, sub-anesthetic ketamine (0.25 mg/kg IV bolus followed by continuous infusion) produced significant reduction in within-network connectivity of the DMN, with the most pronounced decrease observed in PCC-mPFC coupling. This acute DMN disruption correlated with the subjective experience of ego dissolution and derealization -- core features of the dissociative state.
Bonhomme and colleagues (2016) replicated and extended these findings using both rs-fMRI and EEG, demonstrating that ketamine-induced DMN disconnection occurred in a dose-dependent manner and was temporally associated with alterations in conscious experience. At the highest sub-anesthetic doses studied, DMN connectivity approached levels observed during propofol-induced unconsciousness, suggesting a continuum of DMN disruption across the sedation-anesthesia spectrum.
Magnetoencephalography Evidence
Magnetoencephalography (MEG) studies have complemented fMRI findings by providing superior temporal resolution of ketamine's network effects. Muthukumaraswamy and colleagues (2015), published in NeuroImage, used MEG to demonstrate that ketamine produced broadband reductions in oscillatory power across cortical regions, with particular impact on alpha-band (8-13 Hz) and theta-band (4-8 Hz) power within DMN regions. These oscillatory changes -- particularly the reduction in alpha power, which is thought to maintain cortical idling states associated with self-referential processing -- may represent the electrophysiological mechanism through which ketamine disrupts DMN function.
Post-Ketamine DMN Changes: Therapeutic Relevance
24-Hour Post-Infusion Connectivity
Critically, ketamine's effects on DMN connectivity evolve beyond the acute drug state. Several studies have demonstrated that DMN connectivity changes persist or emerge in new configurations at 24-48 hours post-infusion -- the time point coinciding with peak antidepressant effect. Abdallah and colleagues (2017), published in Biological Psychiatry, examined resting-state connectivity in treatment-resistant depression patients before and 24 hours after ketamine infusion. Ketamine responders demonstrated significant normalization of DMN hyperconnectivity -- specifically, reduction of excessive sgACC-to-DMN coupling that had been present at baseline. Non-responders showed no such normalization.
Evans and colleagues (2018) reported that ketamine-induced increases in global brain connectivity (GBC) -- a measure of how connected each brain region is to all others -- were most pronounced in the prefrontal cortex and correlated with antidepressant response at 24 hours, published in Molecular Psychiatry. Importantly, prefrontal GBC increases occurred specifically in regions associated with executive control networks, suggesting that ketamine rebalances the relationship between the DMN and executive control networks in a therapeutically beneficial direction.
Longitudinal Connectivity Changes with Repeated Infusions
Li and colleagues (2020) examined DMN connectivity changes across a series of six ketamine infusions in treatment-resistant depression patients. Progressive normalization of DMN hyperconnectivity was observed with successive infusions, and the degree of connectivity normalization at the end of the infusion series predicted sustained antidepressant response at follow-up, published in Translational Psychiatry. This finding suggests that repeated ketamine administration produces cumulative network-level plasticity that may underlie the observed clinical advantage of multi-infusion protocols over single infusions.
DMN Subnetworks and Ketamine Response
Anterior Versus Posterior DMN
The DMN can be parsed into anterior (mPFC-centered) and posterior (PCC/precuneus-centered) subnetworks with partially dissociable functions. The anterior DMN is more strongly associated with self-referential evaluation and emotional processing, while the posterior DMN supports autobiographical memory and contextual processing (Andrews-Hanna et al., 2010). Emerging evidence suggests that ketamine may differentially affect these subnetworks, with more pronounced acute disruption of posterior DMN connectivity and more therapeutically relevant normalization of anterior DMN hyperconnectivity at the 24-hour time point (Lehmann et al., 2016).
DMN-Salience Network Interaction
The salience network -- anchored in the anterior insula and dorsal ACC -- serves as a "switch" that mediates transitions between DMN-dominated internal processing and task-positive network-dominated external engagement (Menon, 2011). In depression, impaired salience network function may contribute to the inability to disengage from ruminative self-focus. Ketamine has been shown to enhance salience network connectivity and strengthen the anti-correlation between DMN and task-positive networks -- a pattern associated with improved cognitive flexibility and reduced rumination (Kraus et al., 2020).
Predictive Biomarkers: DMN Connectivity as Treatment Response Predictor
Baseline Connectivity Predictors
The potential to use pre-treatment DMN connectivity patterns to predict ketamine response represents a high-priority translational research objective. Preliminary evidence suggests that baseline DMN hyperconnectivity -- paradoxically -- predicts better response to ketamine. Abdallah and colleagues (2017) reported that patients with greater pre-treatment sgACC-DMN connectivity showed larger antidepressant responses, possibly because they had more "room for normalization" in this network measure.
Mkrtchian and colleagues (2021), published in Neuropsychopharmacology, used machine learning applied to pre-treatment resting-state fMRI data to predict ketamine response with approximately 80% accuracy, using features drawn from DMN connectivity patterns, executive control network function, and inter-network coupling. While these prediction models require prospective validation, they demonstrate the feasibility of neuroimaging-guided patient selection for ketamine therapy.
Real-Time Connectivity Monitoring
Advances in real-time fMRI neurofeedback raise the speculative possibility of monitoring DMN connectivity during ketamine infusion and adjusting dose or infusion parameters based on observed network changes. This closed-loop approach, while technologically demanding, could theoretically optimize the neuroplastic effects of each treatment session. Current implementations remain at the proof-of-concept stage.
Mechanistic Implications
NMDA Receptor Blockade and Network Disruption
The acute DMN disruption produced by ketamine is hypothesized to result from NMDA receptor blockade on cortical GABAergic interneurons, particularly within DMN hub regions. This interneuron disinhibition produces a glutamate surge that transiently disrupts the coordinated low-frequency oscillations (particularly in the alpha and theta bands) that maintain DMN connectivity (Anticevic et al., 2012). The disruption is analogous to a "reset" of network dynamics, creating a window of decoupled processing during which maladaptive connectivity patterns may be overwritten.
Synaptic Plasticity and Connectivity Restoration
The post-acute normalization of DMN connectivity at 24-48 hours is hypothesized to reflect the structural plasticity triggered by ketamine's downstream molecular signaling -- BDNF release, mTORC1 activation, and dendritic spine formation in prefrontal cortex neurons. This synaptogenesis may selectively strengthen adaptive connectivity patterns (between DMN and regulatory networks) while allowing maladaptive patterns (DMN hyperconnectivity) to weaken, producing the net connectivity normalization observed in neuroimaging studies (Duman et al., 2016).
Comparison with Other Antidepressant Modalities
Ketamine's effects on DMN connectivity can be compared with those of other antidepressant interventions. SSRI treatment over weeks to months produces gradual normalization of DMN hyperconnectivity, as demonstrated in longitudinal fMRI studies (Posner et al., 2013). ECT produces more rapid DMN connectivity changes, with reduced DMN hyperconnectivity detectable after three to six sessions (Mulders et al., 2015). Ketamine's unique contribution is the speed and magnitude of DMN modulation -- producing network-level changes within hours that parallel the time course of its clinical antidepressant effect. This temporal concordance strengthens the hypothesis that DMN connectivity changes are mechanistically linked to, rather than merely correlated with, antidepressant response.
Future Directions
Key research priorities include prospective validation of DMN-based response prediction models, mechanistic studies linking specific DMN connectivity changes to specific symptom dimensions (rumination, anhedonia, suicidal ideation), and investigation of whether DMN connectivity changes mediate or moderate the relationship between ketamine and clinical outcomes. The integration of multimodal neuroimaging (fMRI, PET, MEG) with peripheral biomarkers and genetic data in large, multi-site studies will be essential for advancing the translational utility of DMN research in ketamine therapy.
Conclusion
Neuroimaging evidence consistently demonstrates that sub-anesthetic ketamine produces rapid and therapeutically relevant modulation of the default mode network. Acute ketamine administration disrupts DMN connectivity in a pattern consistent with reduced self-referential processing, while post-acute connectivity normalization at 24-48 hours correlates with antidepressant response. These network-level effects provide a systems-neuroscience framework for understanding ketamine's mechanism of action and hold promise for the development of neuroimaging biomarkers that can guide patient selection, treatment optimization, and response monitoring. The DMN represents not merely a correlate of ketamine's effects but a potential mechanistic pathway through which NMDA receptor modulation produces rapid antidepressant action.
References
- NIMH: Depression Overview — National Institute of Mental Health clinical information on depression, including neurobiological research and treatment advances
- PubMed: Ketamine-Induced Changes in Plasma BDNF Are Associated with Resting-State Functional Connectivity — Study linking ketamine's neuroplasticity effects to prefrontal cortex functional connectivity changes
- PubChem: Ketamine Compound Summary — NCBI PubChem database entry for ketamine pharmacology and receptor binding profile
- WHO: Depression Fact Sheet — World Health Organization overview of depressive disorders, prevalence, and treatment approaches
Share